Archive - January 2023
Acquisition of Neogene Therapeutics completed
SAE Media Group’s 6th annual 3D Cell Culture Conference
FDA Approves Rykindo (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia and Bipolar 1 Disorder
January 13 2023 – Novo Nordisk’s GLP-1 for Type II diabetes approved for first-line treatment
Study identifies potential new approach for treating lupus
Novo Nordisk Announces FDA Approval of Label Update for Rybelsus (semaglutide) Allowing Use as a First-Line Option for Adults with Type 2 Diabetes
Bayer to accelerate drug discovery with Google Cloud’s high-performance compute power
OPIS: Multilingual Inside Sales (Business Development) United Kingdom